摘要
2022年10月,国家重大公共卫生事件医学中心组织各领域专家共同讨论并制定发布了《重症发热伴血小板减少综合征诊治专家共识》(后简称共识),该共识从发热伴血小板减少综合征(SFTS)的病原学特征、流行病学特征、发病机制、临床特征、实验室检查、诊断、治疗、生物安全防护与预防等方面进行了详尽的阐述和推荐。本文就该共识申明的内容进行详细解读,以期提高我国对于重症SFTS患者的诊治能力。
In October 2022,the National Center for Major Public Health Events brought together leading experts to develop and release the Expert Consensus on the Diagnosis and Treatment of Severe Fever with Thrombocytopenia Syndrome(SFTS).This consensus provides a thorough overview of SFTS,covering its etiology,epidemiology,pathogenesis,clinical features,diagnostic testing,treatment strategies,biosafety protocols,and prevention measures.This article delves into the key points of the consensus,offering insights to improve the diagnosis and management of severe SFTS cases in China.
作者
朱莹
李毓雯
朱传龙
ZHU Ying;LI Yu-wen;ZHU Chuan-long(Department of Infectious Disease,The First Affiliated Hospital of Nanjing Medical University,Jiangsu Nanjing 210029,China;Department of Pediatrics,The First Affiliated Hospital of Nanjing Medical University,Jiangsu Nanjing 210029,China)
出处
《内科急危重症杂志》
2025年第3期193-200,共8页
Journal of Critical Care In Internal Medicine
基金
国家自然科学基金(82472167)。
关键词
发热伴血小板减少综合征
重症
诊断
治疗
共识解读
Severe fever with thrombocytopenia syndrome
Critical illness
Diagnosis
Treatment
Interpretation of consensus
